GURUFOCUS.COM » STOCK LIST » Financial Services » Capital Markets » Greenhill & Co Inc (NYSE:GHL) » Definitions » Research & Development

Greenhill (Greenhill) Research & Development : $0.0 Mil (TTM As of Sep. 2023)


View and export this data going back to 2004. Start your Free Trial

What is Greenhill Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Greenhill's Research & Development for the three months ended in Sep. 2023 was $0.0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Sep. 2023 was $0.0 Mil.


Greenhill Research & Development Historical Data

The historical data trend for Greenhill's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Greenhill Research & Development Chart

Greenhill Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Greenhill Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Greenhill Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Greenhill  (NYSE:GHL) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.


Greenhill Research & Development Related Terms

Thank you for viewing the detailed overview of Greenhill's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.


Greenhill (Greenhill) Business Description

Traded in Other Exchanges
N/A
Address
1271 Avenue of the Americas, New York, NY, USA, 10020
Greenhill & Co Inc is an independent investment bank that provides financial and strategic advice on significant domestic and cross-border mergers and acquisitions, divestitures, restructurings, financings, capital raising, and other transactions to a diverse client base, including corporations, partnerships, institutions, and governments globally. The company derives revenues from both corporate advisory services related to mergers and acquisitions, financings and restructurings and capital advisory services related to sales or capital raises pertaining to alternative assets.
Executives
Mark Lasky officer: Chief Financial Officer C/O GREENHILL & CO., INC., 1271 AVENUE OF THE AMERICAS, 21ST FLOOR, NEW YORK NY 10020
Rodriguez Harold J Jr officer: Mg Dir-Fin, Regn. & Ops.
Scott L Bok director, officer: Chief Executive Officer
Kevin Ferro director C/O KOS PHARMACEUTICALS, INC., 1001 BRICKELL BAY DRIVE, 25TH FLOOR, MIAMI FL 33131
David Wyles officer: Managing Director GREENHILL & CO. INC., 300 PARK AVENUE, NEW YORK NY 10022-7405
Kevin M Costantino officer: President GREENHILL & CO., 300 PARK AVENUE, NEW YORK NY 10022
Gitanjali Pinto Faleiro officer: General Counsel C/O GREENHILL & CO., INC., 300 PARK AVENUE, NEW YORK NY 10022
Meryl D Hartzband director C/O THE NAVIGATORS GROUP, INC., 400 ATLANTIC STREET, 8TH FLOOR, STAMFORD CT 06901
Robert F Greenhill director, officer: Chairman and CEO
Patricia Moran officer: Chief Legal Officer GREENHILL & CO., 300 PARK AVENUE, 17TH FLOOR, NEW YORK NY 10022
Karen P Robards director 800 SCUDDERS MILL RD, PLAINSBORO NJ 08536
Gavin Dean Solotar officer: General Counsel GREENHILL & CO., 300 PARK AVENUE, NEW YORK NY 10022
Christopher Thomas Grubb officer: Chief Financial Officer 300 PARK AVENUE, 23RD FLOOR, NEW YORK NY 10022
John C Danforth director CERNER CORP, 2800 ROCKCREEK PARKWAY, KANSAS CITY MO 64117-2551
Ulrika Ekman officer: General Counsel GREENHILL & CO., INC., 300 PARK AVENUE, NEW YORK NY 10022